成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 1021-25-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1021-25-6
Chemical Structure| 1021-25-6
Structure of 1021-25-6 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 1021-25-6 ]

Related Doc. of [ 1021-25-6 ]

Alternatived Products of [ 1021-25-6 ]
Product Citations

Product Details of [ 1021-25-6 ]

CAS No. :1021-25-6 MDL No. :MFCD00005977
Formula : C13H17N3O Boiling Point : No data available
Linear Structure Formula :- InChI Key :HTQWGIHCFPWKAS-UHFFFAOYSA-N
M.W : 231.29 Pubchem ID :70556
Synonyms :

Calculated chemistry of [ 1021-25-6 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 17
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.46
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 2.0
Molar Refractivity : 77.06
TPSA : 44.37 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.95 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.76
Log Po/w (XLOGP3) : 1.07
Log Po/w (WLOGP) : -0.44
Log Po/w (MLOGP) : 1.27
Log Po/w (SILICOS-IT) : 1.28
Consensus Log Po/w : 0.99

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.14
Solubility : 1.66 mg/ml ; 0.00719 mol/l
Class : Soluble
Log S (Ali) : -1.59
Solubility : 5.9 mg/ml ; 0.0255 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -3.66
Solubility : 0.0505 mg/ml ; 0.000218 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.62

Safety of [ 1021-25-6 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P305+P351+P338 UN#:
Hazard Statements:H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 1021-25-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1021-25-6 ]

[ 1021-25-6 ] Synthesis Path-Downstream   1~4

  • 1
  • [ 2840-44-0 ]
  • [ 1021-25-6 ]
  • 8-(7-fluoro-1,2,3,4-tetrahydro-naphthalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one [ No CAS ]
  • 2
  • [ 26673-30-3 ]
  • [ 1021-25-6 ]
  • [ 779310-74-6 ]
  • 3
  • [ 1021-25-6 ]
  • [ 223575-69-7 ]
  • [ 473527-96-7 ]
YieldReaction ConditionsOperation in experiment
With hydrogenchloride; sodium tris(acetoxy)borohydride; In CHCl3:CH3OH; diethyl ether; 1,2-dichloro-ethane; Step B To a mixture of <strong>[223575-69-7]2-(2-thiazolyl)benzaldehyde</strong> (200 mg, 1.06 mmol) and 1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one (0.232 mg, 1.00 mmol) in 1,2-dichloroethane (20 mL) was added sodium triacetoxyborohydride (376 mg, 1.79 mmol). The resultant mixture was stirred at room temperature for 18 h, quenched with aqueous NaHCO3 (50 mL) and extracted with CHCl3 (2*50 mL). The organic solution was dried over Na2SO4, filtered and concentrated. The crude product was dissolved in 1:1 CHCl3:CH3OH (30 mL) and treated with 2 mL of 1 N HCl in Et2O. The HCl salt was precipitated by addition of Et2O, collected by filtration and dried in the vacuum oven at 60 C. for 18 h to yield the product as an amorphous solid. MS (loop pos): MH+=405.1 (100%) 1H NMR (300 MHz, DMSO d6) 61.50-1.60 (m, 2H), 2.75-2.90 (m, 2H), 3.45-3.55 (m, 2H), 3.75-3.90 (m, 2H), 4.65 (s, 2H), 4.70 (s, 2H), 6.76-6.81 (m, 1H), 6.95-6.98 (m, 2H), 7.18-7.24 (m, 2H), 7.60-7.70 (m, 2H), 7.90-7.99 (m, 3H), 8.14-8.15 (m, 1H), 9.00 (s, 1H), 9.80 (br s, 1H exchangeable).
With sodium tris(acetoxy)borohydride; In 1,2-dichloro-ethane; at 20℃; for 18h; Step B: To a mixture of <strong>[223575-69-7]2-(2-thiazolyl)benzaldehyde</strong> (200 mg, 1.06 mmol) and 1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one (.232 mg, 1.00 mmol) in 1,2-dichloroethane (20 mL) was added sodium triacetoxyborohydride (376 mg, 1.79 mmol). The resultant mixture was stirred at room temperature for 18h, quenched with aqueous NaHCO3 (50 mL) and extracted with CHCl3 (2 x 50 mL). The organic solution was dried over Na2SO4, filtered and concentrated. The crude product was dissolved in 1:1 CHCl3: CH3OH (30 mL) and treated with 2 mL of 1 N HCl in Et2O. The HCl salt was precipitated by addition of Et2O, collected by filtration and dried in the vacuum oven at 60C for 18h to yield the product as an amorphous solid. MS (loop pos): MH+ = 405.1 (100%) 1H NMR (300 MHz, DMSO d6) delta 1.50-1.60 (m, 2H), 2.75-2.90 (m, 2H), 3.45-3.55 (m, 2H), 3.75-3.90 (m, 2H), 4.65 (s, 2H), 4.70 (s, 2H), 6.76-6.81 (m, 1 H), 6.95-6.98 (m, 2H), 7.18-7.24 (m, 2H), 7.60-7.70 (m, 2H), 7.90-7.99 (m, 3H), 8.14-8.15 (m, 1H), 9.00 (s, 1H), 9.80 (br s, 1 H exchangeable).
  • 4
  • [ 1021-25-6 ]
  • [ 170384-29-9 ]
  • C21H32N4O3 [ No CAS ]
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 1021-25-6 ]

Aryls

Chemical Structure| 1272758-31-2

[ 1272758-31-2 ]

3-Phenyl-1,3,8-triazaspiro[4.5]decan-4-one

Similarity: 0.99

Chemical Structure| 170921-48-9

[ 170921-48-9 ]

8-Benzyl-1,3,8-triazaspiro[4.5]decan-4-one

Similarity: 0.75

Chemical Structure| 159857-79-1

[ 159857-79-1 ]

Val-Cit-PAB-OH

Similarity: 0.71

Chemical Structure| 96-88-8

[ 96-88-8 ]

N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamide

Similarity: 0.69

Chemical Structure| 38396-39-3

[ 38396-39-3 ]

1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide

Similarity: 0.69

Amides

Chemical Structure| 1272758-31-2

[ 1272758-31-2 ]

3-Phenyl-1,3,8-triazaspiro[4.5]decan-4-one

Similarity: 0.99

Chemical Structure| 170921-48-9

[ 170921-48-9 ]

8-Benzyl-1,3,8-triazaspiro[4.5]decan-4-one

Similarity: 0.75

Chemical Structure| 159857-79-1

[ 159857-79-1 ]

Val-Cit-PAB-OH

Similarity: 0.71

Chemical Structure| 80636-30-2

[ 80636-30-2 ]

3,3-Dimethyl-3,4-dihydroquinoxalin-2(1H)-one

Similarity: 0.70

Chemical Structure| 96-88-8

[ 96-88-8 ]

N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamide

Similarity: 0.69

Related Parent Nucleus of
[ 1021-25-6 ]

Other Aromatic Heterocycles

Chemical Structure| 86499-35-6

[ 86499-35-6 ]

3-Amino-2,3,4,5-tetrahydro-1H-benzazepin-2-one

Similarity: 0.63

Chemical Structure| 1243415-14-6

[ 1243415-14-6 ]

4-Methyl-3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-one

Similarity: 0.62

Chemical Structure| 5755-07-7

[ 5755-07-7 ]

1,3,4,5-Tetrahydro-2H-1,5-benzodiazepin-2-one

Similarity: 0.60

Chemical Structure| 46155-89-9

[ 46155-89-9 ]

1,3-Dimethyl-1H-pyrrolo[3,2-d]pyrimidine-2,4(3H,5H)-dione

Similarity: 0.58

Chemical Structure| 1000981-77-0

[ 1000981-77-0 ]

2,3-Dihydroimidazo[1,2-a]pyridin-5(1H)-one

Similarity: 0.56

Imidazolidines

Chemical Structure| 1272758-31-2

[ 1272758-31-2 ]

3-Phenyl-1,3,8-triazaspiro[4.5]decan-4-one

Similarity: 0.99

Chemical Structure| 170921-48-9

[ 170921-48-9 ]

8-Benzyl-1,3,8-triazaspiro[4.5]decan-4-one

Similarity: 0.75

Chemical Structure| 2221-13-8

[ 2221-13-8 ]

3-Phenylimidazolidine-2,4-dione

Similarity: 0.69

Chemical Structure| 13625-39-3

[ 13625-39-3 ]

1,3,8-Triazaspiro[4.5]decane-2,4-dione

Similarity: 0.68

Chemical Structure| 78222-09-0

[ 78222-09-0 ]

1,3,7-Triazaspiro[4.5]decane-2,4-dione

Similarity: 0.67

Spiroes

Chemical Structure| 1272758-31-2

[ 1272758-31-2 ]

3-Phenyl-1,3,8-triazaspiro[4.5]decan-4-one

Similarity: 0.99

Chemical Structure| 170921-48-9

[ 170921-48-9 ]

8-Benzyl-1,3,8-triazaspiro[4.5]decan-4-one

Similarity: 0.75

Chemical Structure| 13625-39-3

[ 13625-39-3 ]

1,3,8-Triazaspiro[4.5]decane-2,4-dione

Similarity: 0.68

Chemical Structure| 78222-09-0

[ 78222-09-0 ]

1,3,7-Triazaspiro[4.5]decane-2,4-dione

Similarity: 0.67

Chemical Structure| 699-51-4

[ 699-51-4 ]

1,3-Diazaspiro[4.4]nonane-2,4-dione

Similarity: 0.63

; ;